| 1 |
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al. · Nature Biotechnology
Open access |
13 Aug 2018 |
852 |
| 2 |
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
Eric L. Smith et al. · Science Translational Medicine
Open access |
27 Mar 2019 |
395 |
| 3 |
Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
Hong Liu et al. · Clinical Cancer Research
|
17 Aug 2016 |
233 |
| 4 |
A membrane-associated MHC-I inhibitory axis for cancer immune evasion
Xufeng Chen et al. · Cell
Open access |
Aug 2023 |
209 |
| 5 |
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
Tao Dao, Su Yan, Nicholas J. Veomett et al. · Science Translational Medicine
Open access |
13 Mar 2013 |
184 |
| 6 |
MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits
Hong Liu, Derek C. Radisky, Dun Yang et al. · Nature Cell Biology
Open access |
13 May 2012 |
180 |
| 7 |
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
Tao Dao, Dmitry Pankov, Andrew Scott et al. · Nature Biotechnology
Open access |
21 Sep 2015 |
164 |
| 8 |
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan et al. · Leukemia
Open access |
7 Dec 2016 |
156 |
| 9 |
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
Stephanie M. Salabarria, Manuela Corti, Kirsten E. Coleman et al. · Journal of Clinical Investigation
Open access |
21 Nov 2023 |
147 |
| 10 |
Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector
Eric L. Smith, Mette Stæhr, Reed Masakayan et al. · Molecular Therapy
Open access |
28 Mar 2018 |
127 |
| 11 |
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
Yiyang Xu, Zhiyuan Yang, Lucas H. Horan et al. · Cell Discovery
Open access |
14 Nov 2018 |
122 |
| 12 |
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
Aaron Y. Chang, Tao Dao, Ron S. Gejman et al. · Journal of Clinical Investigation
Open access |
18 Jun 2017 |
95 |
| 13 |
ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
Guilly Rebagay, Su Yan, Cheng Liu et al. · Frontiers in Oncology
Open access |
2012 |
79 |
| 14 |
Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics
Niloufar Ataie, Jingyi Xiang, Neal N. Cheng et al. · Journal of Molecular Biology
Open access |
16 Dec 2015 |
74 |
| 15 |
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias
Leonid Dubrovsky, Dmitry Pankov, Elliott Joseph Brea et al. · Blood
Open access |
11 Apr 2014 |
52 |
| 16 |
Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
Nicholas J. Veomett, Tao Dao, Hong Liu et al. · Clinical Cancer Research
Open access |
21 May 2014 |
50 |
| 17 |
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies
Mahiuddin Ahmed, Andrés López‐Albaitero, Dmitry Pankov et al. · JCI Insight
Open access |
21 Feb 2018 |
49 |
| 18 |
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth
Thapi Dharma Rao, Alberto Fernández‐Tejada, Abram J. Axelrod et al. · ACS Chemical Biology
Open access |
15 Jun 2017 |
40 |
| 19 |
Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
Sung Soo Mun, Jeremy Meyerberg, Leila Peraro et al. · Cancer Immunology Immunotherapy
Open access |
27 Aug 2023 |
38 |
| 20 |
Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition
Oladapo Yeku, Thapi Dharma Rao, Ian Laster et al. · Frontiers in Immunology
Open access |
14 Apr 2021 |
38 |
| 21 |
Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma
Chenggong Li et al. · Journal of Hematology & Oncology
Open access |
21 Jan 2023 |
29 |
| 22 |
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
Tao Dao, Guangyan Xiong, Sung Soo Mun et al. · Blood
Open access |
4 Dec 2023 |
27 |
| 23 |
Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody
Tao Dao, Sung Soo Mun, Andrew Scott et al. · OncoImmunology
Open access |
15 Apr 2019 |
25 |
| 24 |
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies
Martin G. Klatt, Tao Dao, Zhiyuan Yang et al. · Blood
Open access |
15 Apr 2022 |
23 |
| 25 |
Optimizing human α-galactosidase for treatment of Fabry disease
William Casey Hallows, Kristen J. Skvorak, Nick Agard et al. · Scientific Reports
Open access |
23 Mar 2023 |
19 |
| 26 |
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma
Chang Liu et al. · Scientific Reports
Open access |
15 Jul 2022 |
19 |
| 27 |
Directed Evolution of AAV Targeting Primate Retina by Intravitreal Injection Identifies R100, a Variant Demonstrating Robust Gene Delivery and Therapeutic Efficacy in Non-Human Primates
Melissa A. Kotterman, Ghezal Beliakoff, Roxanne H. Croze et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
25 Jun 2021 |
19 |
| 28 |
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
Pengcheng He, Haibo Liu, Bryan Zimdahl et al. · Journal of Cancer Research and Clinical Oncology
Open access |
Jul 2022 |
17 |
| 29 |
Intranasal administration of SARS-CoV-2 neutralizing human antibody prevents infection in mice
Hongbing Zhang, Zhiyuan Yang, Jingyi Xiang et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
9 Dec 2020 |
16 |
| 30 |
Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society
Hongyu Zhang, Mi Deng, Peng Lin et al. · Antibody Therapeutics
Open access |
Sep 2018 |
16 |
| 31 |
Real Time Assays for Quantifying Cytotoxicity with Single Cell Resolution
Sonny C. Hsiao, Hong Liu, Taylor A. Holstlaw et al. · PLoS ONE
Open access |
24 Jun 2013 |
15 |
| 32 |
Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps
Wolfgang Miesbach, Paul A Batty, Pratima Chowdary et al. · Research and Practice in Thrombosis and Haemostasis
Open access |
31 Dec 2024 |
13 |
| 33 |
Batch‐to‐Batch and Within‐Subject Variability: What Do We Know and How Do These Variabilities Affect Clinical Pharmacology and Bioequivalence?
Leslie Z. Benet, Priya Jayachandran, Kevin J. Carroll et al. · Clinical Pharmacology & Therapeutics
Open access |
16 Jan 2019 |
13 |
| 34 |
CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
Melissa Divya Mathias, Jonathan T. Sockolosky, Aaron Y. Chang et al. · Leukemia
Open access |
12 Jul 2017 |
13 |
| 35 |
Engineered T Cell Receptor-Mimic Antibody, (TCRm) Chimeric Antigen Receptor (CAR) T Cells Against the Intracellular Protein Wilms Tumor-1 (WT1) for Treatment of Hematologic and Solid Cancers
Sarwish Rafiq, Tao Dao, Liu C et al. · Blood
|
6 Dec 2014 |
11 |
| 36 |
Development of JCARH125: Optimization of a Fully Human Anti-Bcma CAR for Use in the Treatment of Multiple Myeloma
Kim Harrington et al. · University of Southern Denmark Research Portal (University of Southern Denmark)
|
7 Dec 2017 |
10 |
| 37 |
Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease
Melissa A. Calton et al. · American Journal of Respiratory Cell and Molecular Biology
|
22 Oct 2025 |
8 |
| 38 |
A Therapeutic TCR Mimic Monoclonal Antibody for Intracellular PRAME Protein in Leukemias
Aaron Y. Chang, Tao Dao, Andrew Scott et al. · Blood
|
3 Dec 2015 |
8 |
| 39 |
CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1T315I mutation mouse model
Yuting Tan, Lin Ye, Fei Xie et al. · Haematologica
Open access |
19 Sep 2019 |
7 |
| 40 |
Generation of TCR-Like Antibodies Using Phage Display
Brian H. Santich, Hong Liu, Liu C et al. · Methods in molecular biology
Book chapter |
2015 |
7 |
| 41 |
Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins
Sara M. O’Rourke, Bin Yu, Javier F. Morales et al. · Journal of Immunological Methods
Open access |
28 Nov 2018 |
6 |
| 42 |
Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity
Leonid Dubrovsky, Elliott Joseph Brea, Dmitry Pankov et al. · OncoImmunology
Open access |
3 Aug 2016 |
6 |
| 43 |
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation
Brandon E. Nemieboka, Sai Kiran Sharma, Thapi Dharma Rao et al. · Nuclear Medicine and Biology
Open access |
May 2020 |
5 |
| 44 |
A Bi-Specific T Cell Engaging Monoclonal Antibody (mAb) Derived From a TCR-Like Mab Specific For WT1/HLA-A0201 (ESK-BiTE) Shows a Potent Activity Against Human AML and Ph+ ALL In Mouse Models
Dmitry Pankov, Tao Dao, Yiyang Wang et al. · Blood
|
15 Nov 2013 |
5 |
| 45 |
Assessment of Immune Responses Against AAV Encoded Transgene Products
Boris Gorovits et al. · The AAPS Journal
|
5 Jan 2026 |
4 |
| 46 |
Real-time Cytotoxicity Assays in Human Whole Blood
Ching-Wen Hsiao, Yen-Ting Lo, Hong Liu et al. · Journal of Visualized Experiments
Open access |
7 Nov 2014 |
2 |
| 47 |
High-avidity cathepsin-G–specific CAR T cells for the treatment of acute myeloid leukemia
Tara A. Walhart et al. · Blood
|
20 Aug 2026 |
1 |
| 48 |
IL-12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancer
Lupita S. Lopez, Ziyou Cui, Yukiko Yamaguchi et al. · Molecular Therapy Advances
Open access |
3 Apr 2026 |
1 |
| 49 |
Trispecific targeting of T cells engineered with TCR mimic antibodies to limit antigen escape
Tao Dao, Guangyan Xiong, Jeremy Meyerberg et al. · Journal for ImmunoTherapy of Cancer
Open access |
2026 |
1 |
| 50 |
Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density
Alex Quan, Mingyu Huo, Dan Li et al. · Cell Reports Medicine
Open access |
Oct 2025 |
1 |